No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ADUS240719C90000
- 11.47
- 0.000.00%
15min DelayTrading Feb 27 14:10 ET
0.00High0.00Low
0.00Open11.47Pre Close0 Volume6 Open Interest90.00Strike Price0.00Turnover68.51%IV-13.76%PremiumJul 19, 2024Expiry Date27.66Intrinsic Value100Multiplier16DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9728Delta0.0037Gamma4.21Leverage Ratio-0.0437Theta0.0391Rho4.09Eff Leverage0.0157Vega
Intraday
- 5D
- Daily
News
Express News | Addus Homecare Announces Closing of Public Offering
Express News | Addus Homecare Corp : Macquarie Initiates Coverage With Outperform Rating; Target Price $136
BofA Securities Maintains Addus HomeCare(ADUS.US) With Buy Rating
BofA Securities analyst Joanna Gajuk maintains $Addus HomeCare(ADUS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 55.0% and a total average return of 0.0% over t
Getting In Cheap On Addus HomeCare Corporation (NASDAQ:ADUS) Is Unlikely
Addus HomeCare Corporation's (NASDAQ:ADUS) price-to-earnings (or "P/E") ratio of 30.7x might make it look like a strong sell right now compared to the market in the United States, where around half of
Addus HomeCare Initiated at Outperform by Macquarie
Addus HomeCare Initiated at Outperform by Macquarie
Express News | Macquarie Initiates Coverage On Addus HomeCare With Outperform Rating, Announces Price Target of $136
Comments
Addus HomeCare's rising ROCE and capital employed are positive signs. The stock's past five-year performance suggests investors may be overlooking these promising trends, indicating potential investment opportunities.
Returns Are Gaining Momentum At Addus HomeCare (NASDAQ:ADUS)The stock is undervalued, presenting a buying opportunity as future growth isn't fully reflected in the price. Consider the company's capital structure and management record before investing.
1
Insiders' lack of purchases last year may concern investors, but their ownership indicates alignment with investors. The largest recent insider sale matching the current share price could hint at limited growth. However, investment decisions shouldn't rely solely on directors' actions.
Addus HomeCare's rising ROCE and regular business investment make it a worthwhile consideration for investors. Its capacity to boost returns while expanding capital hints at future growth possibilities. Despite recent 27% return to shareholders, the company's growth potential may still be underestimated.
Upgrades
• $Booz Allen Hamilton Holding Corp(BAH.US$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $Humana(HUM.US$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB Hunt Transport Services(JBHT.US$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB Hunt Transport Services(JBHT.US$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI International(CACI.US$: Goldman Sachs Downgrad...
• $Booz Allen Hamilton Holding Corp(BAH.US$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $Humana(HUM.US$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB Hunt Transport Services(JBHT.US$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB Hunt Transport Services(JBHT.US$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI International(CACI.US$: Goldman Sachs Downgrad...
9
2
?Read more